prostate cancer
Showing NaN - NaN of 186
Prostate Cancer Trial in Vancouver, Toronto (Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab)
Recruiting
- Prostate Cancer
- Apalutamide 60mg Tab
- +5 more
-
Vancouver, British Columbia, Canada
- +1 more
May 25, 2022
Prostate Cancer Trial in Canada (Peer navigation, Active wait list control)
Recruiting
- Prostate Cancer
- Peer navigation
- Active wait list control
-
Vancouver, British Columbia, Canada
- +4 more
May 17, 2022
Prostate Cancer Trial in Worldwide (Multiparametric MRI +/- prostate biopsy, Biparametric MRI +/- prostate biopsy)
Recruiting
- Prostate Cancer
- Multiparametric MRI +/- prostate biopsy
- Biparametric MRI +/- prostate biopsy
-
Rochester, Minnesota
- +30 more
May 11, 2022
Prostate Cancer Trial in Toronto (MS3TMRI / TRUS Guided Biopsy)
Recruiting
- Prostate Cancer
- MS3TMRI / TRUS Guided Biopsy
-
Toronto, Ontario, CanadaSunnybrook Odette Cancer Centre
May 5, 2022
Prostate Cancer Trial in Toronto (Hyperpolarized Pyruvate (13C))
Recruiting
- Prostate Cancer
- Hyperpolarized Pyruvate (13C)
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
May 4, 2022
Prostate Cancer Trial in Toronto (focal salvage HDR prostate brachytherapy)
Active, not recruiting
- Prostate Cancer
- focal salvage HDR prostate brachytherapy
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre, Odette Cancer Centre
May 3, 2022
Prostate Cancer Trial in Toronto (Sterotactic Body Radiotherapy, Conventionally Fractionated Radiation)
Recruiting
- Prostate Cancer
- Sterotactic Body Radiotherapy
- Conventionally Fractionated Radiation
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
May 3, 2022
Prostate Cancer Trial in Canada (Abiraterone acetate with prednisone, Leuprolide, Cabazitaxel with peg-filgrastim)
Completed
- Prostate Cancer
- Abiraterone acetate with prednisone
- +2 more
-
Vancouver, British Columbia, Canada
- +4 more
Apr 13, 2022
Prostate Cancer Trial in Toronto (Nurse Ned Clinic)
Recruiting
- Prostate Cancer
- Nurse Ned Clinic
-
Toronto, Ontario, CanadaUniversity Health Network (Princess Margaret Hospital)
Mar 30, 2022
Prostate Cancer Trial in Australia, Canada, United Kingdom (18F-FCH PET/MRI Scan)
Completed
- Prostate Cancer
- 18F-FCH PET/MRI Scan
-
Sydney, New South Wales, Australia
- +9 more
Apr 4, 2022
Prostate Cancer Trial in Hamilton, London, Toronto (18F-DCFPyL PET/CT scan)
Completed
- Prostate Cancer
- 18F-DCFPyL PET/CT scan
-
Hamilton, Ontario, Canada
- +3 more
Mar 24, 2022
Prostate Cancer Trial in Canada (Durvalumab, Tremelimumab)
Active, not recruiting
- Prostate Cancer
-
Kelowna, British Columbia, Canada
- +10 more
Mar 14, 2022
Prostate Cancer Trial in Toronto (Conventionally Fractionated versus Hypofractionated Boost)
Active, not recruiting
- Prostate Cancer
- Conventionally Fractionated versus Hypofractionated Boost
-
Toronto, Ontario, CanadaSunnybrook Odette Cancer Centre
Mar 6, 2022
Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Cancer of the Prostate Trial in Worldwide (Enzalutamide,
Active, not recruiting
- Nonmetastatic Castration-Resistant Prostate Cancer
- +2 more
- Enzalutamide
- Placebo
-
Tucson, Arizona
- +396 more
Feb 22, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Prostate Cancer Trial in Linz, Toronto (Micro-US Targeted Biopsy, MRI Targeted Biopsy)
Not yet recruiting
- Prostate Cancer
- Micro-US Targeted Biopsy
- MRI Targeted Biopsy
-
Linz, Austria
- +1 more
Jan 20, 2022
Prostate Cancer Trial in Canada (Palbociclib)
Active, not recruiting
- Prostate Cancer
-
Halifax, Nova Scotia, Canada
- +6 more
Jan 28, 2022
Prostate Cancer Trial in Hamilton, London, Toronto (Molecular Imaging)
Completed
- Prostate Cancer
- Molecular Imaging
-
Hamilton, Ontario, Canada
- +2 more
Dec 20, 2021
Prostate Cancer Trial in Canada, United States (Enzalutamide, Active Surveillance)
Completed
- Prostate Cancer
- Enzalutamide
- Active Surveillance
-
Birmingham, Alabama
- +53 more
Oct 14, 2021
Prostate Cancer Trial in Canada, United States (Brachytherapy (100/110), Brachytherapy (125/145), External Beam Radiation
Unknown status
- Prostate Cancer
- Brachytherapy (100/110)
- +2 more
-
Phoenix, Arizona
- +169 more
Nov 2, 2021
Prostate Cancer Trial in Toronto (Volumetric Modulated Arc Therapy (VMAT) and High-Dose Rate (HDR) Radiotherapy, No Active
Active, not recruiting
- Prostate Cancer
- Volumetric Modulated Arc Therapy (VMAT) and High-Dose Rate (HDR) Radiotherapy
- No Active Treatment - completed Prior Radiation
-
Toronto, Ontario, CanadaUniversity Health Network, The Princess Margaret
Oct 4, 2021
Prostate Cancer Trial in Toronto (whole-mount sectioning of the prostate)
Active, not recruiting
- Prostate Cancer
- whole-mount sectioning of the prostate
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 4, 2021
Prostate Cancer Trial in Toronto (18F-Fluoroazomycin Arabinoside (18F-FAZA))
Recruiting
- Prostate Cancer
- 18F-Fluoroazomycin Arabinoside (18F-FAZA)
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 4, 2021
Prostate Cancer Trial in Toronto (targeted focal HDR brachytherapy, Whole-gland HDR Brachytherapy)
Recruiting
- Prostate Cancer
- targeted focal HDR brachytherapy
- Whole-gland HDR Brachytherapy
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 4, 2021